An approved GHRH analog — useful contrast to unapproved research secretagogues.
Also known as: Egrifta
Part of the Growth hormone & IGF peptides cluster
Overview
Tesamorelin is a synthetic growth hormone–releasing hormone analog approved in some countries for specific labeled indications. It is an important benchmark in GHRH-analog education.
Source & context
Biological / chemical source: Synthetic GHRH analog
Primary research or clinical context: Approved in some markets for specific HIV-associated indications
Approved vs research landscape
Tesamorelin illustrates how a GHRH pathway peptide can become a regulated medicine with defined indications, manufacturing standards, and labeling — unlike many research-only secretagogues.
FAQ about Tesamorelin
What is Tesamorelin?+
Tesamorelin is a synthetic growth hormone–releasing hormone analog approved in some countries for specific labeled indications. It is an important benchmark in GHRH-analog education.
Is Tesamorelin an approved medicine?+
Tesamorelin: Approved in some markets for specific HIV-associated indications. Always follow licensed medical guidance for approved products.
What is the typical length of Tesamorelin?+
Tesamorelin is commonly described as approximately 44 amino acids (GHRH analog).